Ardaman Shergill, MD, is a skilled oncologist who specializes in providing comprehensive care to patients with all stages of lung and gastrointestinal cancers, with an expertise in treating colon, rectal and appendix cancers.
In combination with her clinical work, Dr. Shergill uses research to improve care for her patients. Currently, she is developing novel therapies so she can offer her patients’ innovative clinical trials for lung and gastrointestinal cancers. Dr. Shergill is also an executive officer for experimental therapeutic trials at Alliance for Clinical Trials in Oncology, a National Cancer Institute funded oncology research organization.
Dr. Shergill is an active researcher and she has been published in several peer-reviewed journals, including Cancer Informatics, Clinical Lymphoma, Myeloma and Leukemia and the Journal of Pharmacology & Experimental Therapeutics.
Specialties
Areas of Expertise
- Gastrointestinal Cancers
- Lung Cancer
- Colon Cancer
- Rectal Cancer
- Appendix Cancer
- Peritoneal Malignancies
Board Certifications
- Internal Medicine
- Oncology
Memberships & Medical Societies
- American Society of Clinical Oncology
- American Society of Hematology
- International Association for the Study of Lung Cancer
- American Association for Cancer Research
Languages Spoken
- Punjabi
- Hindi
- English
Medical Education
- Wayne State University School of Medicine
Internship
- University of Illinois Medical Center Chicago
Residency
- University of Illinois Medical Center Chicago
Fellowship
- University of Illinois Medical Center Chicago
- Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial
- Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer
- Regorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal Cancer
- Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer
- Savolitinib in Treating Patients With MET Amplified Metastatic or Unresectable Colorectal Cancer
- Evaluation of Pembrolizumab (MK-3475) or Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer (CRC) (MK-1308A-008)
- A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- JAB-3312 Activity in Adult Patients With Advanced Solid Tumors
- Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive Biomarker
- Study of Lenvatinib (MK-7902/E7080) in Combination With Pembrolizumab (MK-3475) Versus Standard of Care in Participants With Metastatic Colorectal Cancer (MK-7902-017/E7080-G000-325/LEAP-017)
- Aetna HMO (specialists only)
- Aetna POS
- Aetna PPO
- BCBS Blue Precision HMO (specialists only)
- BCBS HMO (HMOI) (specialists only)
- BCBS PPO
- Cigna HMO
- Cigna POS
- Cigna PPO
- CountyCare *see insurance page
- Aetna Better Health *see insurance page
- Medicare
- Multiplan PPO
- PHCS PPO
- United Choice Plus POS/PPO
- United Options (PPO)
- United Select (HMO & EPO) (specialists only)
- United W500 Emergent Wrap
- Aetna Medicare Advantage HMO & PPO
- BCBS Medicare Advantage HMO & PPO
- Humana Medicare Advantage Choice PPO
- Humana Medicare Advantage Gold Choice PFFS
- Humana Medicare Advantage Gold Plus HMO
- United Choice HMO (specialists only)
- University of Chicago Health Plan (UCHP)
Our list of accepted insurance providers is subject to change at any time. You should contact your insurance company to confirm UChicago Medicine participates in their network before scheduling your appointment. If your insurance company is not listed here, or if you have any other questions, please contact Managed.Care@uchospitals.edu.
To Request an Appointment
Duchossois Center for Advanced Medicine (DCAM) - Hyde Park
Request an Appointment at Duchossois Center for Advanced Medicine (DCAM) - Hyde Park
To Refer a Patient
Refer a Patient